CAS 1303607-60-4

Fórmula: C29H34Cl2FN3O3

InChI: InChI=1S/C29H34Cl2FN3O3/c1-28(2,3)14-22-29(19-12-7-15(30)13-21(19)34-27(29)38)23(18-5-4-6-20(31)24(18)32)25(35-22)26(37)33-16-8-10-17(36)11-9-16/h4-7,12-13,16-17,22-23,25,35-36H,8-11,14H2,1-3H3,(H,33,37)(H,34,38)/t16?,17?,22-,23-,25+,29+/m0/s1

Chave InChI: IDKAKZRYYDCJDU-AEPXTFJPSA-N

SMILES: CC(C)(C)C[C@H]1[C@@]2([C@H]([C@@H](N1)C(=O)NC3CCC(CC3)O)C4=C(C(=CC=C4)Cl)F)C5=C(C=C(C=C5)Cl)NC2=O

SAR405838

CAS: 1303607-60-4

SAR405838

Fórmula: C₂₉H₃₄Cl₂FN₃O₃

Pureza: 98.5%

Peso molecular: 562.5

Ref: 54-BUP02994

SAR405838

CAS: 1303607-60-4

Fórmula: C₂₉H₃₄Cl₂FN₃O₃

Pureza: 95%

Peso molecular: 562.5030

Ref: IN-DA009BPE

MI-77301

Produto Controlado

CAS: 1303607-60-4

Fórmula: C₂₉H₃₄Cl₂FN₃O₃

Cor e Forma: Neat

Peso molecular: 562.503

Ref: TR-M341100

SAR 405838

CAS: 1303607-60-4

HDM2 antagonist; inhibits interaction between MDM2 and p53

Fórmula: C₂₉H₃₄Cl₂FN₃O₃

Pureza: Min. 95%

Cor e Forma: White To Yellow Solid

Peso molecular: 562.5 g/mol

Ref: 3D-FC76168

SAR405838

CAS: 1303607-60-4

MI-773 (SAR405838 (MI 773)) is an orally available MDM2 antagonist with Ki of 0.88 nM. Phase 1.

Fórmula: C₂₉H₃₄Cl₂FN₃O₃

Pureza: 98.63%

Cor e Forma: Solid

Peso molecular: 562.503

Ref: TM-T6585